Capsule Endoscopy Market By Product Type (Capsules {Small Bowel Capsule, Colon Capsule, Esophageal Capsule, Stomach Capsule}, Workstations {Data Recorders, Workstations & Software}, and Accessories {Sensor Belts & Arrays, Wires & Leads, Capsule Delivery Devices}), By Application (Crohn’s Disease, Celiac Disease, Gastrointestinal Bleeding, Polyps & Tumors, Small Bowel Disorders, Inflammatory Bowel Disease (IBD), and Others), By Technology (Wireless Capsule Endoscopy (WCE), Optical Imaging Technology, Narrow Band Imaging (NBI), Virtual Chromoendoscopy, AI-powered Image Analysis, and 3D Imaging & Robotics Integration), By Component (Capsule Endoscopes, Data Recorders, Workstations, and Others), and By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Imaging & Specialty Clinics, and Research Institutes & Universities), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape Capsule Endoscopy Market in the coming years?

The Capsule Endoscopy Market accounted for USD 458.73 Million in 2024 and USD 494.24 Million in 2025 is expected to reach USD 1041.61 Million by 2035, growing at a CAGR of around 7.74% between 2025 and 2035. The capsule endoscopy market is the production and sale of small, swallowable camera-equipped capsules to make diagnostic images of the gastrointestinal (GI) tract. Thousands of images are captured by these capsules on their way to the digestive system to diagnose such conditions as bleeding, Crohn’s disease, ulcers, and tumours. The technology is a non-invasive and patient-friendly alternative to the conventional endoscopy techniques. The rising cases of GI disorders, the rising ageing population, and developments in imaging technologies are the major influencing factors in market expansion. The players in the market are those who produce medical devices and the health providers, and the diagnostic facilities.

What do industry experts say about the Capsule Endoscopy market trends?

"Capsule endoscopy has revolutionized our ability to visualize the small intestine, an area once considered a diagnostic blind spot. It offers a minimally invasive way to detect obscure gastrointestinal bleeding, Crohn’s disease, and small-bowel tumors."

• Dr. Richard S. Bloomfeld, Professor of Internal Medicine, Section on Gastroenterology, Wake Forest University School of Medicine (USA)

"The strength of capsule endoscopy lies in its patient comfort and diagnostic reach. It reduces the need for more invasive procedures and improves early detection of gastrointestinal disorders."

• Dr. Ralf Kiesslich, Chief Physician of Internal Medicine, Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Capsule Endoscopy market?

How does aging population increase demand for digestive tract diagnostics?

The ageing population is largely demanding digestive tract diagnostics such as capsule endoscopy because of the higher occurrence of gastrointestinal diseases in older people. The World Health Organisation states that individuals over 60 years old already constitute a significant segment of the world population, and this patient group is further subjected to a higher incidence of diseases like colorectal cancer, inflammatory bowel disease, and diverticular disease.

According to the American Cancer Society, the incidence of colorectal cancer increases sharply above the age of 50 years, and the most frequent incidence among patients is observed among individuals over 65 years of age. It is also the ageing that presents physiological changes to the digestive system that can be manifested in symptoms that require in-depth inquiry.

One such minimally invasive diagnostic technique, capsule endoscopy, which enables the visualisation of the small intestine, is helpful with elderly patients who might be at more risk with conventional invasive methods. Consequently, the existing demographic density and the disease burden are the main causes of the growing popularity of sophisticated digestive tract diagnostics.

What role does non-invasive technology play in patient compliance improvement?

Technologies like capsule endoscopy, which operate without invasiveness, play a major role in boosting patient compliance since they reduce discomfort and the need to use sedation or invasive devices, thus endorsing the procedure to the patients. A study that was published in the National Institutes of Health (NIH) revealed that patients who had undergone the capsule endoscopy, as compared to those who underwent traditional endoscopy, were more satisfied and had a propensity to do the procedure again because it was easy and not invasive.

Another point that is made by the Centers for Disease Control and Prevention (CDC) is that the less invasive diagnostic methods promote a higher rate of patient involvement in screening programmes, which is pivotal in the early detection of gastrointestinal diseases. Studies by academic medical centres demonstrate that the completion rates of capsule endoscopy are above 85 per cent, which is very high in comparison with traditional practices.

The fact that it is possible to do the procedure either as an outpatient or at home also decreases the obstacles associated with hospital attendance and improves compliance. Non-invasive technologies help to ensure better health outcomes with higher screening and adherence rates by ensuring medical diagnostics are conducted in a way that is more comfortable and convenient for the patient.

What factors contribute to insufficient awareness among general practitioner circles?

The major reason behind the lack of awareness of capsule endoscopy among the general practitioners (GPs) is related to exposure in the medical school setting and the absence of continuing education opportunities that relate to this state-of-the-art diagnostic tool. Most GPs have little practical exposure to capsule endoscopy, with the practice frequently being localised to expert gastroenterology units only.

A 2021 report by the National Institutes of Health (NIH) demonstrates that less than 30% of primary care providers had been trained or updated on the topics of capsule endoscopy in their continuing medical education (CME) programmes. Moreover, the Centers for Disease Control and Prevention (CDC) emphasises that most GPs prefer to use the conventional methods of diagnosis because they are familiar and are readily available, and newer technologies are not utilised.

The lack of patient referrals to specialists performing capsule endoscopy adds to this gap and leaves GPs without a chance to watch and understand the clinical advantages of this practice. CME and inclusion of capsule endoscopy modules in GP training can be a key intervention to address this gap in knowledge and contribute to improved patient outcomes and higher levels of diagnosis of gastrointestinal disorders in early stages.

What is the potential of emerging markets in driving future adoption? write ans of the above-mentioned opportunity for Capsule Endoscopy

Emerging markets promise to be influential to the future uptake of capsule endoscopy because of improved investment in healthcare, a rise in gastrointestinal disease prevalence, and the expansion of healthcare facilities. The World Health Organisation (WHO) has reported a rapid increase in non-communicable diseases in some countries, such as India and China, such as gastrointestinal disorders, and this would result in an increased need for sophisticated diagnostic instruments.

The Ministry of Health in India reports that the government is making efforts to enhance early diagnosis using new technologies, and the National Health Commission in China is focused on modernisation of gastrointestinal health care as a part of overall reforms. These countries are investing in capsule endoscopy to enhance better patient outcomes and reduce traditional endoscopy dependence with big, ageing populations and growing awareness of the minimally invasive approach to endoscopy.

Access is further promoted through the expansion of insurance cover and government-funded screening programmes. Capsule endoscopy is also embraced in the clinical training of educational institutions and hospitals in these regions, increasing the level of acceptability and patient confidence among the clinicians. This combination of demographic trends and government support shows that emerging markets will be instrumental in boosting global adoption.

Can wireless connectivity advancements improve real-time monitoring effectiveness?

The development of wireless connectivity is transforming the concept of capsule endoscopy through improved real-time monitoring capabilities essential in timely and accurate gastrointestinal diagnostics. Wireless transmission technologies, including ultra-wideband and MIMO antenna systems synthesised in the academic literature, can be used to transmit data faster and more reliably to ensure that the data transfer between the capsule in the body and the external receivers is continuous without any delays. Research at universities such as Durham and Monash has demonstrated that such systems ensure high signal integrity and limit positional errors, which are critical to accurate lesion detection.

The study conducted by the University of Maryland points to the possibility of using wireless biosensors to present physiological information in real time, which helps in the diagnosis at the earliest possible stage. The National Institutes of Health (NIH) explains that wireless medical devices have enhanced patient outcomes since they allow them to have real-time insights and monitor the patient remotely. These developments greatly enhance the efficacy of capsule endoscopy because they enable quick and evidence-based clinical decision-making and improved treatment of patients.

What are the key market segments in the Capsule Endoscopy industry?

Based on the product type, the Capsule Endoscopy Market is classified into Capsules, Workstations, and Accessories. Capsules are the most noticeable and dominant product segment in the capsule endoscopy market. This is mainly because of their fundamental role in carrying out minimally invasive gastrointestinal diagnostic procedures. Capsules are also constantly improving in imaging and battery life and in their ability to transmit data, improving the accuracy of the diagnostic process and patient experience. The growing popularity of GI diseases and the need to carry out non-invasive interventions further solidify their top position in the market, as they are widely spread in terms of usage within hospitals and diagnostic centres.

Based on the application, the Capsule Endoscopy Market is classified into Crohn’s Disease, Celiac Disease, Gastrointestinal Bleeding, Polyps & Tumors, Small Bowel Disorders, Inflammatory Bowel Disease (IBD), and Others. Gastrointestinal (GI) bleeding is the most visible and the leading application segment in the capsule endoscopy market. This is because capsule endoscopy is very effective in the identification of obscure GI bleeding, particularly in the small intestine, where conventional endoscopy fails in certain instances. The latter is a favourite diagnostic tool for unexplained bleeding due to the technological capacity to deliver a detailed image of the entire GI tract. The increase in GI bleeding disorder prevalence, especially in the elderly, serves as an additional demand pull in this segment, making it a major market growth driver.

Which regions are leading the Capsule Endoscopy market, and why?

The North American capsule endoscopy market is dominant because of its well-developed healthcare system and use of novel medical equipment. The healthcare provider and research institutions within the area have already developed a strong network of healthcare providers that actively support early diagnosis and less invasive surgery, which contributes to the demand for capsule endoscopy. The growing number of gastrointestinal diseases, such as Crohn's disease and colorectal cancer, contributes to the demand for effective diagnostic solutions. These technologies are also more accessible due to strong reimbursement policies and increased healthcare expenditure.

Furthermore, the market development in North America is also boosted by constantly increasing investments in research and development and by the education of healthcare providers and patients. Rapid technological development and the availability of products are also attributed to the presence of key market players in the region where they have their head offices. Moreover, the increase in patient preference towards non-invasive methods of diagnostics promotes the perpetuated demand and market growth.

The Asia Pacific capsule endoscopy market is leading because of various factors. A growing incidence of gastrointestinal disorders with the shift in lifestyles and a growing urbanisation has increased the demand for high-tech diagnostic instruments. The rising awareness of minimally invasive procedures and the advantages of the use of the capsule endoscopy in comparison with the established ones has contributed to the uptake in this area.

The growth of healthcare infrastructure, together with the rising programme undertaken by the government to enhance diagnostic opportunities, encourages the growth of the market. The high number of patients, enhanced affordability of medical devices, and increasing investments by major players in nations such as China, Japan, and India all add to the dominance of the region. Overall, the Asia Pacific is one of the leaders in the capsule endoscopy market due to the combination of medical care, technological achievements, and favourable economic factors.

What does the competitive landscape of the Capsule Endoscopy market look like?

The capsule endoscopy market is one of the most competitive markets owing to the blistering technology and the rising need for non-invasive gastrointestinal diagnostics. The major players, such as Medtronic plc, Olympus Corporation, CapsoVision, and IntroMedic Co., Ltd., control the space with constant innovation in enhancing image quality, battery life, and comfort for the patients. The most recent ones involve the introduction of superior AI-based diagnostic devices by Medtronic, which simplify the analysis of data and enhance their detection rate.

Olympus has diversified its range of products to incorporate more manoeuvrable capsule systems and those that provide real-time views. New entrants like AnX Robotica Corporation are also launching robot-assisted capsules to offer a stronger level of control in the processes. These inventions, through strategic alliances and market expansions, are creating more competition and creating markets across the world.

The increasing understanding of gastrointestinal diseases and the use of capsule endoscopy in the emerging economies will likely provide new revenue generation opportunities in the years ahead. Another driving force to market growth is the high level of investment in R&D by manufacturers to improve the functionality of capsules and lower costs that will enable them to increase their market share.

Capsule Endoscopy Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Capsule Endoscopy industry?

• In January 2025, CapsoVision, Inc. received FDA clearance for the CapsoCam Plus® capsule endoscopy system. This approval allowed patients to swallow the capsule from home under virtual supervision. The new feature expanded access, improved patient comfort, and supported telehealth integration.

Report Coverage:

By Product Type

• Capsules
  • Small Bowel Capsule
  • Colon Capsule
  • Esophageal Capsule
  • Stomach Capsule
• Workstations
  • Data Recorders
  • Workstations & Software
• Accessories
  • Sensor Belts & Arrays
  • Wires & Leads
  • Capsule Delivery Devices

By Application

• Crohn’s Disease
• Celiac Disease
• Gastrointestinal Bleeding
• Polyps & Tumors
• Small Bowel Disorders
• Inflammatory Bowel Disease (IBD)
• Others

By Technology

• Wireless Capsule Endoscopy (WCE)
• Optical Imaging Technology
• Narrow Band Imaging (NBI)
• Virtual Chromoendoscopy
• AI-powered Image Analysis
• 3D Imaging & Robotics Integration

By Component

• Capsule Endoscopes
• Data Recorders
• Workstations
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Imaging & Specialty Clinics
• Research Institutes & Universities

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic plc
• Olympus Corporation
• CapsoVision, Inc.
• IntroMedic Co., Ltd.
• Chongqing Jinshan Science & Technology Co., Ltd.
• RF System Lab
• Check‑Cap Ltd.
• AnX Robotica Corporation
• Fujifilm Holdings Corporation
• AccuRead Endoscopy Inc.
• Boston Scientific Corporation
• Northside Gastroenterology Endoscopy Center, LLC
• Interscope Inc.
• BioCam GmbH
• EndoChoice, Inc.

Frequently Asked Questions (FAQs)